Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity: 2020-2025

Historic Return on Equity for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to 136.86%.

  • Biodesix's Return on Equity rose 13822.00% to 136.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 136.86%, marking a year-over-year increase of 13822.00%. This contributed to the annual value of -3.36% for FY2024, which is 68.00% up from last year.
  • Per Biodesix's latest filing, its Return on Equity stood at 136.86% for Q3 2025, which was up 2,112.80% from -6.80% recorded in Q2 2025.
  • Biodesix's 5-year Return on Equity high stood at 136.86% for Q3 2025, and its period low was -32.47% during Q4 2023.
  • Its 3-year average for Return on Equity is 22.55%, with a median of -1.75% in 2024.
  • Over the last 5 years, Biodesix's Return on Equity had its largest YoY gain of 13,822bps in 2025, and its largest YoY loss of 10,156bps in 2025.
  • Biodesix's Return on Equity (Quarterly) stood at -2.54% in 2021, then slumped by 409bps to -6.63% in 2022, then crashed by 2,584bps to -32.47% in 2023, then spiked by 3,071bps to -1.75% in 2024, then skyrocketed by 13,822bps to 136.86% in 2025.
  • Its Return on Equity was 136.86% in Q3 2025, compared to -6.80% in Q2 2025 and -2.51% in Q1 2025.